Lawley Lori D

CIK 00017477161 companyAMES, IA

SEC Profile

Transactions

Companies

Filings

CIK

0001747716

Recent Transactions

50 trades

Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−1,282→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−12,000→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−2,776→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−12,000→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Common Stock
2024-12-12−12,284→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−12,000→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−21,250→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−25,000→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−4,628→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−10,625→ 0 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2024-08-01$1.79/sh−229→ 12,284 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2024-04-01$2.84/sh−274→ 12,513 total
Award
LUMOS PHARMA, INC.
Common Stock
2024-04-01$2.84/sh+1,000→ 12,787 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-04-01+12,000→ 12,000 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2024-02-01$3.01/sh−215→ 11,787 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2023-08-01$3.28/sh−229→ 11,502 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2023-04-01$3.31/sh−274→ 11,231 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2023-02-01+12,000→ 12,000 total
Award
LUMOS PHARMA, INC.
Common Stock
2023-02-01$3.52/sh+1,000→ 11,619 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2023-02-01$3.52/sh−114→ 11,505 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2022-08-01$8.17/sh−229→ 10,119 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2022-04-01$9.23/sh−274→ 9,848 total
Award
LUMOS PHARMA, INC.
Common Stock
2022-02-01$10.02/sh+1,000→ 10,187 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2022-02-01$10.02/sh−65→ 10,122 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2022-02-01+12,000→ 12,000 total
Award
LUMOS PHARMA, INC.
Common Stock
2021-08-01+3,750→ 9,187 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2021-08-01+21,250→ 21,250 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2021-04-01$12.25/sh−274→ 5,437 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2021-02-01+10,625→ 10,625 total
Award
LUMOS PHARMA, INC.
Common Stock
2021-02-01+869→ 5,711 total
Award
LUMOS PHARMA, INC.
Common Stock
2020-04-01+4,500→ 4,842 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2020-04-01+25,000→ 25,000 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+98→ 98 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+98→ 98 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31−3,334→ 0 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+487→ 487 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+360→ 360 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+729→ 729 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31−2,000→ 0 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+1,111→ 1,111 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31−2,352→ 0 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+311→ 311 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+1,250→ 1,250 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+146→ 146 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+105→ 105 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+187→ 187 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+868→ 868 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+472→ 472 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31+70→ 70 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2019-07-31−10,000→ 0 total

Companies

LUMOS PHARMA, INC.
Principal Accounting Officer

Recent Filings

Address

C/O NEWLINK GENETICS CORPORATION 2503 SOUTH LOOP DR.

AMES, IA, 50010

View on SEC.gov